{"title": "Tr\u00e1fico y se\u00f1alizaci\u00f3n relacionados con la inmunidad en la piel humana asociados con el tratamiento con l\u00e1ser infrarrojo de baja potencia", "author": "Beckman Laser Institute; Medical Center", "url": "https://ichgcp.net/es/clinical-trials-registry/NCT02453113", "hostname": "ichgcp.net", "description": "El prop\u00f3sito de esto es que el investigador pueda usar una dosis no dolorosa y no da\u00f1ina de tratamiento con l\u00e1ser infrarrojo cercano de baja potencia para cambi.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2015-04-22", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Tr\u00e1fico y se\u00f1alizaci\u00f3n relacionados con la inmunidad en la piel humana asociados con el tratamiento con l\u00e1ser infrarrojo de baja potencia\n[University of California, Irvine](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=University%20of%20California%2C%20Irvine)\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\nIntervenci\u00f3n / Tratamiento\nDescripci\u00f3n detallada\nEl investigador puede usar exposiciones de un minuto de luz l\u00e1ser de baja potencia administradas a la piel en dosis no dolorosas y no da\u00f1inas. Esto result\u00f3 en cambios inmunol\u00f3gicos significativos en la piel que incluyeron la regulaci\u00f3n al alza de genes espec\u00edficos de la piel y tejidos de la piel y la activaci\u00f3n y movilizaci\u00f3n de c\u00e9lulas espec\u00edficas de la piel.\nEn la primera parte del estudio, el investigador determinar\u00e1 la irradiaci\u00f3n l\u00e1ser que se tolerar\u00e1. La irradiancia m\u00e1s alta que tolera el sujeto durante 1 minuto se identificar\u00e1 como la irradiancia m\u00e1xima tolerable de ese sujeto. Despu\u00e9s de que todos los sujetos hayan sido evaluados, el investigador seleccionar\u00e1 la irradiaci\u00f3n m\u00e1s alta que se toler\u00f3 y la usar\u00e1 en la segunda fase del estudio.\nAproximadamente 24 horas despu\u00e9s de las primeras exposiciones de prueba, cada sujeto recibir\u00e1 un tratamiento l\u00e1ser de un minuto con la m\u00e1xima irradiaci\u00f3n tolerable. Cuatro horas m\u00e1s tarde, se recolectar\u00e1n dos biopsias de piel del sitio tratado con l\u00e1ser y del sitio no tratado.\nUna muestra de tejido se analizar\u00e1 en el Departamento de Dermatopatolog\u00eda de UC Irvine para evaluar cambios microsc\u00f3picos en la piel, una muestra de piel se enviar\u00e1 al Hospital General de Massachusetts para evaluar la expresi\u00f3n de ARN y prote\u00ednas.\nTipo de estudio\nInscripci\u00f3n (Actual)\nFase\n- No aplica\nContactos y Ubicaciones\nUbicaciones de estudio\n-\nEstados Unidos\n-\nCalifornia\n-\nIrvine, California, Estados Unidos, 92612\n- Beckman Laser Institute\n-\n-\nMassachusetts\n-\nCharlestown, Massachusetts, Estados Unidos, 02129\n- Vaccine and Immunotherapy Center Massachusetts General Hospital\n-\n-\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nG\u00e9neros elegibles para el estudio\nDescripci\u00f3n\nCriterios de inclusi\u00f3n:\n- Hombres y mujeres adultos con piel tipo 1 y 2\n- No embarazada\nCriterio de exclusi\u00f3n:\n- Uso de esteroides sist\u00e9micos, esteroides t\u00f3picos, soluciones bronceadoras y anticoagulantes\n- Antecedentes de VIH, mentalmente incompetente, preso, alcohol o drogas\n- Fotosensibilidad anormal\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Prop\u00f3sito principal: Otro\n- Asignaci\u00f3n: N / A\n- Modelo Intervencionista: Asignaci\u00f3n de un solo grupo\n- Enmascaramiento: Ninguno (etiqueta abierta)\nArmas e Intervenciones\n|\n|\nGrupo de participantes/brazo\n|\n|\nIntervenci\u00f3n / Tratamiento\n|\n|\nOtro: l\u00e1ser de baja potencia\nSe\u00f1alizaci\u00f3n en la piel humana asociada con el tratamiento con l\u00e1ser infrarrojo de baja potencia\n|\n|\nSe\u00f1alizaci\u00f3n en la piel humana asociada con el tratamiento con l\u00e1ser infrarrojo de baja potencia\n\u00bfQu\u00e9 mide el estudio?\nMedidas de resultado primarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nCambio en la respuesta del tejido de la piel a una vacuna\nPeriodo de tiempo: hasta 12 meses\n|\n|\nSe medir\u00e1 el cambio en las c\u00e9lulas inflamatorias con l\u00e1ser de bajo nivel.\n|\n|\nhasta 12 meses\nColaboradores e Investigadores\nPatrocinador\nColaboradores\nInvestigadores\n- Investigador principal: Kristen Kelly, MD, Beckman Laser Institute\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio\nFinalizaci\u00f3n primaria (Actual)\nFinalizaci\u00f3n del estudio (Actual)\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (Estimar)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Actual)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- 20151840\nPlan de datos de participantes individuales (IPD)\n\u00bfPlanea compartir datos de participantes individuales (IPD)?\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre Respuesta a la vacuna alterada\n-\nNCT05923970A\u00fan no reclutandoRespuesta a la vacuna alterada | Fracaso de vacunaci\u00f3n\n-\nNCT05089565ReclutamientoInfecci\u00f3n por SARS-CoV2 | Sarcoidosis | Respuesta a la vacuna alterada\n-\nNCT05060991Reclutamiento\n[Impacto del ajuste de la inmunosupresi\u00f3n en la respuesta a la vacunaci\u00f3n contra la COVID-19 en receptores de trasplante renal (ADIVKT)](https://ichgcp.net/es/clinical-trials-registry/NCT05060991)COVID-19 | Inmunosupresi\u00f3n | Respuesta a la vacuna alterada\n-\nNCT05019248Reclutamiento\n[Respuesta inmunitaria a la vacunaci\u00f3n contra la influenza estacional en pacientes con esclerosis m\u00faltiple que reciben cladribina (CIRMS)](https://ichgcp.net/es/clinical-trials-registry/NCT05019248)Esclerosis M\u00faltiple Recurrente-Remitente | Respuesta a la vacuna alterada\n-\nNCT04776005ReclutamientoTumor solido | C\u00e1ncer tor\u00e1cico | Malignidad hematol\u00f3gica | C\u00e1ncer relacionado con el tratamiento | Respuesta a la vacuna alterada\n-\nNCT04770649ReclutamientoReacci\u00f3n adversa a la vacuna | Respuesta a la vacuna alterada\n-\nNCT04743947ReclutamientoRespuesta a la vacuna alterada | Enfermedad renal cr\u00f3nica etapa 5 en di\u00e1lisis | Enfermedad Renal Cr\u00f3nica Estadio 5 Con Trasplante\n-\nNCT04852796TerminadoCOVID-19 | Malignidad hematol\u00f3gica | Respuesta a la vacuna alterada\n-\nNCT03713801SuspendidoEnvejecimiento | Respuesta a la vacuna alterada\n-\nNCT05791851TerminadoInfecciones por VIH | Hepatitis B | Respuesta a la vacuna alterada\nEnsayos cl\u00ednicos sobre l\u00e1ser de baja potencia\n-\nNCT05656833Reclutamiento\n-\nNCT05911607TerminadoCuraci\u00f3n del alveolo por extracci\u00f3n\n-\nNCT05865275TerminadoSensibilidad dental\n-\nNCT05816200TerminadoS\u00edndrome de boca ardiente\n-\nNCT05034068Terminado\n[Terapia con l\u00e1ser de bajo nivel versus bencidamina en la prevenci\u00f3n y el tratamiento de la mucositis oral](https://ichgcp.net/es/clinical-trials-registry/NCT05034068)Estomatitis (mucositis oral)\n-\nNCT03015116TerminadoFascitis plantar\n-\nNCT03164252TerminadoTerapia con l\u00e1ser, nivel bajo\n-\nNCT02737241TerminadoHiperplasia prost\u00e1tica\n-\nNCT02240563TerminadoTiroiditis autoinmune\n-\nNCT02817152TerminadoDiabetes mellitus | Periodontitis Cr\u00f3nica", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT02453113", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT02453113&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT02453113", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=University%20of%20California%2C%20Irvine", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Vaccine%20Response%20Impaired", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=low%20power%20laser", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=low%20power%20laser", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=University%20of%20California%2C%20Irvine", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Massachusetts%20General%20Hospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Beckman%20Laser%20Institute%20University%20of%20California%20Irvine", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT05923970", "https://ichgcp.net/es/clinical-trials-registry/NCT05089565", "https://ichgcp.net/es/clinical-trials-registry/NCT05060991", "https://ichgcp.net/es/clinical-trials-registry/NCT05019248", "https://ichgcp.net/es/clinical-trials-registry/NCT04776005", "https://ichgcp.net/es/clinical-trials-registry/NCT04770649", "https://ichgcp.net/es/clinical-trials-registry/NCT04743947", "https://ichgcp.net/es/clinical-trials-registry/NCT04852796", "https://ichgcp.net/es/clinical-trials-registry/NCT03713801", "https://ichgcp.net/es/clinical-trials-registry/NCT05791851", "https://ichgcp.net/es/clinical-trials-registry/NCT05656833", "https://ichgcp.net/es/clinical-trials-registry/NCT05911607", "https://ichgcp.net/es/clinical-trials-registry/NCT05865275", "https://ichgcp.net/es/clinical-trials-registry/NCT05816200", "https://ichgcp.net/es/clinical-trials-registry/NCT05034068", "https://ichgcp.net/es/clinical-trials-registry/NCT03015116", "https://ichgcp.net/es/clinical-trials-registry/NCT03164252", "https://ichgcp.net/es/clinical-trials-registry/NCT02737241", "https://ichgcp.net/es/clinical-trials-registry/NCT02240563", "https://ichgcp.net/es/clinical-trials-registry/NCT02817152", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/canada", "https://ichgcp.net/es/cro-list/country/colombia", "https://ichgcp.net/es/cro-list/country/dominican_republic", "https://ichgcp.net/es/cro-list/country/ireland", "https://ichgcp.net/es/cro-list/country/liberia", "https://ichgcp.net/es/cro-list/country/montenegro", "https://ichgcp.net/es/cro-list/country/new_zealand", "https://ichgcp.net/es/cro-list/country/panama", "https://ichgcp.net/es/cro-list/country/rwanda", "https://ichgcp.net/es/cro-list/country/saudi_arabia", "https://ichgcp.net/es/cro-list/country/singapore", "https://ichgcp.net/es/cro-list/country/taiwan", "https://ichgcp.net/es/cro-list/country/turkey", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/france/company/nda_regulatory_science_nda_group", "https://ichgcp.net/es/cro-list/country/france/company/caidya", "https://ichgcp.net/es/cro-list/country/france/company/aepodia", "https://ichgcp.net/es/cro-list/country/france/company/harrison_clinical", "https://ichgcp.net/es/cro-list/country/france/company/iqvia", "https://ichgcp.net/es/cro-list/country/france/company/ad_hoc_clinical", "https://ichgcp.net/es/cro-list/country/france/company/ppd", "https://ichgcp.net/es/cro-list/country/france/company/aixial", "https://ichgcp.net/es/cro-list/country/france/company/eag_laboratories", "https://ichgcp.net/es/cro-list/country/france/company/pra_health_sciences", "https://ichgcp.net/es/cro-list/country/france", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT02453113", "https://ichgcp.net/de/clinical-trials-registry/NCT02453113", "https://ichgcp.net/clinical-trials-registry/NCT02453113", "https://ichgcp.net/es/clinical-trials-registry/NCT02453113", "https://ichgcp.net/fr/clinical-trials-registry/NCT02453113", "https://ichgcp.net/it/clinical-trials-registry/NCT02453113", "https://ichgcp.net/hu/clinical-trials-registry/NCT02453113", "https://ichgcp.net/nl/clinical-trials-registry/NCT02453113", "https://ichgcp.net/no/clinical-trials-registry/NCT02453113", "https://ichgcp.net/pl/clinical-trials-registry/NCT02453113", "https://ichgcp.net/pt/clinical-trials-registry/NCT02453113", "https://ichgcp.net/fi/clinical-trials-registry/NCT02453113", "https://ichgcp.net/sv/clinical-trials-registry/NCT02453113", "https://ichgcp.net/cs/clinical-trials-registry/NCT02453113", "https://ichgcp.net/ru/clinical-trials-registry/NCT02453113", "https://ichgcp.net/ja/clinical-trials-registry/NCT02453113", "https://ichgcp.net/zh/clinical-trials-registry/NCT02453113", "https://ichgcp.net/ko/clinical-trials-registry/NCT02453113", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}